Tech Company Financing Transactions

AxioMx Funding Round

Connecticut Innovations and Elm Street Ventures participated in a $2 million funding round for AxioMx. The funding round was announced on 12/27/2012.

Transaction Overview

Company Name
Announced On
12/27/2012
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
688 E Main St.
Branford, CT 06405
USA
Email Address
Overview
AxioMx has developed synthetic recombinant antibody libraries with greater than ten billion unique clones. Diversity in our libraries is restricted to the most variable positions in the complementarity determining regions (CDRs) of natural antibody sequences.
Profile
AxioMx LinkedIn Company Profile
Social Media
AxioMx Company Twitter Account
Company News
AxioMx News
Facebook
AxioMx on Facebook
YouTube
AxioMx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christopher McLeod
  Christopher McLeod LinkedIn Profile  Christopher McLeod Twitter Account  Christopher McLeod News  Christopher McLeod on Facebook
Chief Scientific Officer
Michael Weiner
  Michael Weiner LinkedIn Profile  Michael Weiner Twitter Account  Michael Weiner News  Michael Weiner on Facebook
VP - Sales
Tom Thompson
  Tom Thompson LinkedIn Profile  Tom Thompson Twitter Account  Tom Thompson News  Tom Thompson on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/27/2012: Appconomy venture capital transaction
Next: 12/27/2012: CloverApp venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary